PRECISION BIOSCIENCES INC — Director's Dealing 2021

Apr 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-04-15

Reporting Person: JANTZ DEREK (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-15	Common Stock	M	21514	$0.04	Acquired	4002758	Direct
2021-04-15	Common Stock	S	9676	$8.76	Disposed	3993082	Direct
2021-04-16	Common Stock	M	21514	$0.04	Acquired	4014596	Direct
2021-04-16	Common Stock	S	9675	$8.84	Disposed	4004921	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-15	Employee Stock Option (Right to Buy)	$0.04	M	21514	Disposed	2021-05-17	Common Stock (21514)	Direct
2021-04-16	Employee Stock Option (Right to Buy)	$0.04	M	21514	Disposed	2021-05-17	Common Stock (21514)	Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

F2: The option is fully vested and exercisable.